Novo Nordisk's Wegovy Pill Now Broadly Available Across U.S.

By Dominic Chopping

Novo Nordisk's Wegovy weight-loss pill is now broadly available across the U.S., two weeks after it received U.S. regulatory approval, the Danish drugmaker said Monday.

The pill--a tablet formulation of its Wegovy shot--is now available through over 70,000 U.S. pharmacies such as CVS and Costco, and telehealth providers including Ro, LifeMD, Weight Watchers, NovoCare Pharmacy and GoodRx, among others.

The company's shares were 3.1% higher in European afternoon trade and have risen around 12% since U.S. FDA approval was granted on Dec. 22.

The once-daily pill is the first GLP-1 weight-loss pill to hit the market, with Eli Lilly only recently filing for U.S. approval of its own GLP-1 weight-loss tablet.

The Wegovy pill is being sold at a cash price of $149 a month for the starting dose of 1.5 milligrams. The 4 milligram dose will also be available for $149 a month through April 15, before rising to $199 a month later.

The highest 9 milligram and 25 milligram doses will be available for $299 a month, it said.

Trials of the Wegovy pill have shown patients can lose an average of 16.6% of their weight after 64 weeks of consistent use, when used with a reduced calorie diet and exercise.

Write to Dominic Chopping at dominic.chopping@wsj.com

(END) Dow Jones Newswires

January 05, 2026 08:47 ET (13:47 GMT)